CompaniesByCap
BNGO
Bionano Genomics Inc. (BNGO)
NASDAQ · Healthcare

Bionano Genomics Inc. Income Statement 2017–2025

Income StatementBalance SheetCash Flow
Dec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017
Revenues
Revenue28.5M30.8M36.1M27.8M18.0M8.5M10.1M12.0M9.5M
Gross Profit13.2M380,0009.6M5.9M3.9M2.8M3.4M3.3M3.5M
Profitability
Operating Income-33.3M-104.0M-215.2M-131.7M-77.1M-38.6M-25.9M-20.4M-23.2M
EBITDA-23.8M-90.0M-201.5M-122.1M-73.8M-37.1M-24.7M-19.1M-21.7M
Net Income-26.4M-112.0M-232.5M-132.6M-72.4M-41.1M-29.8M-18.5M-23.4M
Per Share Data
EPS (diluted)
Shares Outstanding (dil.)5M1M1M29M277M190M34M10M0M

Bionano Genomics Inc. Income Statement — FAQ

Bionano Genomics Inc. (BNGO) income statement over the last 9 years — annual and quarterly figures with year-over-year growth and charts.

Where can I see BNGO's income statement history?

The chart and table above show Bionano Genomics Inc.'s income statement by year and by quarter, including the growth rate.